Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Signs of Familial Hypercholesterolemia: Very High LDL, Family Pattern and Physical Clues

Signs of Familial Hypercholesterolemia: Very High LDL, Family Pattern and Physical Clues

The main sign of familial hypercholesterolemia, or FH, is a number: an LDL cholesterol of 190 mg/dL or higher in an adult, usually present since youth. Add a parent, brother, sister or child with very high cholesterol or early heart disease, and FH becomes a real possibility.

FH is an inherited condition in which the body clears LDL cholesterol poorly from birth. Some people develop visible cholesterol deposits. Others have no outward sign, which is one reason the condition is so often missed.

Key takeaways

  • An adult LDL cholesterol at or above 190 mg/dL is the usual trigger for asking about FH.
  • Most people with LDL that high do not carry an FH gene variant, but those who do face much higher risk.
  • Deposits in tendons, around the eyelids or at the edge of the cornea can point to FH.
  • Ten-year risk calculators are not meant for people with LDL in this range.
  • Each child of a person with FH has a one in two chance of having it, so relatives get tested.

The number that raises the question

Clinicians call an untreated LDL cholesterol of 190 mg/dL or more severe hypercholesterolemia. In a large genetic study, about 7% of US adults had LDL cholesterol that high.1

Only a small part of that group has FH in the genetic sense. When researchers sequenced the three main FH genes in people with LDL of 190 mg/dL or higher, fewer than 2% carried an FH mutation. The rest have high LDL for other reasons, and recent expert guidance stresses a thorough check for other causes before settling on FH.

Why FH is riskier than the same LDL without it

If the LDL number is the same, does the cause matter? The same study says it does. Compared with people whose LDL was under 130 mg/dL and who had no mutation, people with LDL of 190 mg/dL or higher and no mutation had about 6 times the risk of coronary artery disease. Those with LDL that high and an FH mutation had about 22 times the risk.1

The likely reason is time. A person with FH has had high LDL since childhood, so the arteries have been exposed for decades longer than a single adult blood test suggests. The researchers found that mutation carriers had higher cumulative exposure to LDL cholesterol over the years than non-carriers.

The family pattern

FH is usually inherited from one parent. Each child of a person with the common form has a 50% chance of inheriting it.2 The pattern to look for:

  • A parent, sibling or child with very high LDL cholesterol, often noticed young.
  • Heart attacks, stents or bypass surgery at early ages on one side of the family.
  • A relative who died suddenly at a young age from a heart problem.

Our guide to family history of early heart disease explains which relatives and ages count as early. FH is one of the specific things that history can be pointing to.

Physical signs

Cholesterol that stays very high for years can settle in tissues where a doctor can see or feel it.

SignWhat it looks like
Tendon xanthomasCholesterol deposits in the Achilles tendons or the tendons of the hands
XanthelasmaYellowish, waxy patches around the eyelids
Corneal arcusA white, gray or blue ring at the edge of the cornea, appearing at a younger age than usual

A standard genetics reference describes all three: xanthomas that may be visible in the Achilles tendons or hand tendons and worsen with age, deposits around the eyelids, and a corneal ring that can appear at a younger age in people with FH than in those without it.2

These are possible findings, not required ones. The blood test and the family history carry more weight.

Why risk calculators do not apply

Most people get a 10-year risk percentage before any decision about cholesterol treatment. FH is an exception. The 2018 US cholesterol guideline advised treating adults with LDL cholesterol of 190 mg/dL or higher without calculating 10-year risk at all.3

A calculator sees one cholesterol reading, not a lifetime of exposure, so it can underestimate risk in a younger adult with FH.

The same caution applies to heart scans. A coronary calcium score of zero normally supports waiting, but the 2026 US guideline lists familial hypercholesterolemia among the situations where a zero should not be read that way.4

How FH is confirmed

Diagnosis rests on three things: the LDL level, the family history and a physical exam. Clinicians combine them using formal scoring criteria. Genetic testing can confirm the diagnosis by finding a variant in one of the genes that control LDL clearance, most often LDLR, APOB or PCSK9.

Other causes of high LDL get checked along the way. Our guide on thyroid and heart risk covers one of them.

A European expert panel estimated that fewer than 1% of people with FH had been diagnosed in most countries.5 A 2026 National Lipid Association consensus puts the global prevalence at about 1 in 311 and still describes the condition as severely underdiagnosed.

Cascade testing: why relatives get checked

Because FH is passed down with a one in two chance for each child, finding one person with FH is a reason to test the family. This is called cascade testing: parents, siblings and children are checked first, then the relatives of anyone found to have it.

Relatives can be tested with a gene test when the family variant is known, or with an LDL cholesterol measurement when it is not. The 2026 National Lipid Association consensus recommends systematic cascade screening in families, along with universal cholesterol screening in childhood.6

FH is treatable, and care works best when it starts early. Which treatment fits is a decision for you and your clinician, often with a lipid specialist.

Your next step

If your LDL has been 190 mg/dL or higher, or high cholesterol and early heart disease run together in your family, raise FH by name with your doctor. Then read our guide to heart tests worth having with a family history and our chart of LDL cholesterol levels by risk.

You can also answer the three quick questions in the screener on the Cardio Res-Q program page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

My LDL is 195. Do I have FH?

Not necessarily. In a large sequencing study, fewer than 2% of adults with LDL cholesterol of 190 mg/dL or higher carried an FH mutation. An LDL that high still deserves attention, and family history helps decide whether FH testing is worthwhile.

Can I have FH without any visible signs?

Yes. Tendon deposits, eyelid patches and an early corneal ring are possible findings, not requirements. FH is identified mainly from LDL cholesterol levels and family history, with genetic testing as confirmation.

Can a healthy diet and exercise bring FH cholesterol down to normal?

Healthy habits matter for everyone with FH, and expert guidance lists them as the first step. FH is caused by an inherited problem with clearing LDL, though, and the same guidance describes medication as part of standard care. Talk through the options with your clinician.

Should my children be tested?

If you have FH, each child has a 50% chance of having it, and expert groups recommend checking close relatives. A recent US lipid consensus also supports cholesterol screening for all children. Your child's pediatrician can advise on timing.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Khera AV, et al. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol 2016. PMID 27050191 · doi:10.1016/j.jacc.2016.03.520↩
  2. Ison HE, et al. Familial Hypercholesterolemia. GeneReviews [Internet]. University of Washington, Seattle 2025. PMID 24404629↩
  3. Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019. PMID 30586774 · doi:10.1161/CIR.0000000000000625↩
  4. Blumenthal RS, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2026. PMID 41824552 · doi:10.1161/CIR.0000000000001423↩
  5. Nordestgaard BG, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013. PMID 23956253 · doi:10.1093/eurheartj/eht273↩
  6. Ahmad Z, et al. Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association. J Clin Lipidol 2026. PMID 41741298 · doi:10.1016/j.jacl.2026.01.011↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify